Advanced Solid Tumor

Showing NaN - NaN of 34

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Advanced Solid Tumor Trial in United States (CLN-617, Pembrolizumab)

Not yet recruiting
  • Advanced Solid Tumor
  • Los Angeles, California
  • +5 more
Sep 12, 2023

Advanced Solid Tumor, Hepatocellular Carcinoma Trial in Los Angeles (TORL-4-500)

Not yet recruiting
  • Advanced Solid Tumor
  • Hepatocellular Carcinoma
  • Los Angeles, California
    UCLA - JCCC Clinical Research Unit
Aug 23, 2023

Advanced Solid Tumor, Colorectal Cancer Trial in Los Angeles (TORL-3-600)

Not yet recruiting
  • Advanced Solid Tumor
  • Colorectal Cancer
  • Los Angeles, California
    UCLA - JCCC Clinical Research Unit
Jul 20, 2023

Tumor, Tumor, Solid, Metastasis Trial in United States (nab-sirolimus)

Recruiting
  • Tumor
  • +20 more
  • Mobile, Alabama
  • +81 more
Jan 24, 2023

Advanced Solid Tumor Trial in United States (AGEN1571, Balstilimab, Botensilimab)

Recruiting
  • Advanced Solid Tumor
  • Los Angeles, California
  • +4 more
Jan 17, 2023

Advanced Solid Tumor Trial (HLX23)

Withdrawn
  • Advanced Solid Tumor
  • Los Angeles, California
  • +5 more
Jan 13, 2023

Advanced Solid Tumor, Castration-Resistant Prostatic Cancer, Malignant Melanoma Trial in United States (MGC018, lorigerlimab)

Recruiting
  • Advanced Solid Tumor
  • +6 more
  • vobramitamab duocarmazine
  • lorigerlimab
  • Los Angeles, California
  • +7 more
Jan 10, 2023

Advanced Solid Tumor, Malignant Solid Tumor Trial in Japan, United States (DS-7300a)

Recruiting
  • Advanced Solid Tumor
  • Malignant Solid Tumor
  • Los Angeles, California
  • +21 more
Jan 5, 2023

Advanced Solid Tumor, Gynecologic Cancer Trial in Worldwide (Lucitanib, Nivolumab)

Suspended
  • Advanced Solid Tumor
  • Gynecologic Cancer
  • Los Angeles, California
  • +26 more
Dec 16, 2022

Advanced Solid Tumor Trial in Spain, United Kingdom, United States (AFM24, Atezolizumab 840 MG in 14 ML Injection)

Recruiting
  • Advanced Solid Tumor
  • AFM24
  • Atezolizumab 840 MG in 14 ML Injection
  • Los Angeles, California
  • +5 more
Dec 5, 2022

Advanced Solid Tumor Trial in Los Angeles (EP0031)

Recruiting
  • Advanced Solid Tumor
  • Los Angeles, California
  • +3 more
Dec 1, 2022

Advanced Solid Tumor Trial in Canada, United States (SRF617, Gemcitabine, Albumin-Bound Paclitaxel)

Active, not recruiting
  • Advanced Solid Tumor
  • Duarte, California
  • +9 more
Nov 28, 2022

Advanced Solid Tumor, Advanced/ Metastatic Renal Cell Carcinoma (RCC), Microsatellite Iinstability-high (MSI-H) or Mismatch

Active, not recruiting
  • Advanced Solid Tumor
  • +3 more
  • TP-1454 monotherapy
  • TP-1454 combination therapy
  • Phoenix, Arizona
  • +8 more
Nov 18, 2022

KRAS Mutation-Related Tumors, Metastatic Solid Tumor, Advanced Solid Tumor Trial in United States (TPX-0005, Trametinib)

Active, not recruiting
  • KRAS Mutation-Related Tumors
  • +2 more
  • Los Angeles, California
  • +5 more
Nov 7, 2022

Advanced Solid Tumor Trial in United States (Part 1 ES002023, Part 2 ES002023)

Active, not recruiting
  • Advanced Solid Tumor
  • Part 1 ES002023
  • Part 2 ES002023
  • Scottsdale, Arizona
  • +6 more
Oct 18, 2022

Advanced Solid Tumor, Breast Cancer, Small-cell Lung Cancer Trial in United States (SY-5609, Fulvestrant, Gemcitabine)

Recruiting
  • Advanced Solid Tumor
  • +3 more
  • Gilbert, Arizona
  • +16 more
Sep 13, 2022

Advanced Solid Tumor, Ovarian Cancer, Endometrial Cancer Trial in Los Angeles, Minneapolis, Rochester (TORL-1-23)

Recruiting
  • Advanced Solid Tumor
  • +2 more
  • Los Angeles, California
  • +2 more
Sep 8, 2022

Advanced Solid Tumor Trial in Los Angeles, Nashville, Dallas (UCT-01-097, Gemcitabine, Paclitaxel)

Recruiting
  • Advanced Solid Tumor
  • Los Angeles, California
  • +2 more
Sep 8, 2022

Advanced Solid Tumor, Advanced Malignant Tumor, Metastatic Cancer Trial in United States (PC14586)

Recruiting
  • Advanced Solid Tumor
  • +3 more
  • Los Angeles, California
  • +10 more
Aug 12, 2022

Advanced Solid Tumor Trial in Los Angeles, Dallas, San Antonio (UCT-03-008)

Recruiting
  • Advanced Solid Tumor
  • Los Angeles, California
  • +2 more
Jul 25, 2022

Solid Tumor, Adult, Advanced Solid Tumor, Metastatic Solid Tumor Trial in United Kingdom, United States (Etigilimab dosing,

Recruiting
  • Solid Tumor, Adult
  • +2 more
  • Phoenix, Arizona
  • +15 more
Jun 6, 2022

Advanced Solid Tumor, NSCLC, Melanoma Trial in United States (AB308, Zimberelimab)

Recruiting
  • Advanced Solid Tumor
  • +9 more
  • Phoenix, Arizona
  • +20 more
May 2, 2022

Advanced Solid Tumor Trial in United States (AGEN1223, AGEN1223 and balstilimab)

Terminated
  • Advanced Solid Tumor
  • Scottsdale, Arizona
  • +3 more
Feb 15, 2022